Alternative novel therapies for the treatment of elderly acute myeloid leukemia patients-Reference-Cited by-同舟云学术

Alternative novel therapies for the treatment of elderly acute myeloid leukemia patients

Published:2013-12 Issue:6 Volume:6 Page:767-784
ISSN:1747-4086
Container-title:Expert Review of Hematology
language:en
Short-container-title:Expert Review of Hematology

Author:

Isidori Alessandro,Venditti Adriano,Maurillo Luca,Buccisano Francesco,Loscocco Federica,Manduzio Palma,Sparaventi Giovanni,Amadori Sergio,Visani Giuseppe

Publisher

Informa UK Limited

Subject

Hematology

Link

http://www.tandfonline.com/doi/pdf/10.1586/17474086.2013.858018

Reference99 articles.

1. Cancer statistics, 2013

2. Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry

3. Older Patients With Acute Myeloid Leukemia Benefit From Intensive Chemotherapy: An Update From the Swedish Acute Leukemia Registry

4. Progress in the treatment of acute myeloid leukemia

5. Intensive chemotherapy does not benefit most older patients (age 70 years or older) with acute myeloid leukemia

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunotherapy in Acute Myeloid Leukemia: Where We Stand;Frontiers in Oncology;2021-05-10

2. Gene expression profile predicts response to the combination of tosedostat and low-dose cytarabine in elderly AML;Blood Advances;2020-10-19

3. Caring for AML Patients During the COVID-19 Crisis: An American and Italian Experience;Frontiers in Oncology;2020-09-02

4. Aging of Natural Killer Cells in Acute Myeloid Leukemia;Geriatric Oncology;2020

5. Genomic profiling and predicting treatment response in acute myeloid leukemia;Pharmacogenomics;2019-05